Efficacy and safety of insulin degludec in Japanese patients with type 1 and type 2 diabetes: 24‐week results from the observational study in routine clinical practice

This is first observational prospective study of insulin degludec in routine clinical practice that we evaluated the effect on glycemic control and risk of hypoglycemia in basal‐bolus insulin therapy. We found that insulin degludec can maintain glycemic control at a lower insulin dose and frequency...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobuke, Kazuhiro, Yoneda, Masayasu, Nakanishi, Shuhei, Ohno, Haruya, Maeda, Shusaku, Egusa, Genshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718095/
https://www.ncbi.nlm.nih.gov/pubmed/26816606
http://dx.doi.org/10.1111/jdi.12373
_version_ 1782410737973460992
author Kobuke, Kazuhiro
Yoneda, Masayasu
Nakanishi, Shuhei
Ohno, Haruya
Maeda, Shusaku
Egusa, Genshi
author_facet Kobuke, Kazuhiro
Yoneda, Masayasu
Nakanishi, Shuhei
Ohno, Haruya
Maeda, Shusaku
Egusa, Genshi
author_sort Kobuke, Kazuhiro
collection PubMed
description This is first observational prospective study of insulin degludec in routine clinical practice that we evaluated the effect on glycemic control and risk of hypoglycemia in basal‐bolus insulin therapy. We found that insulin degludec can maintain glycemic control at a lower insulin dose and frequency of hypoglycemia in type 1 diabetes, while it can improve glycemic control at equally insulin dose in type 2 diabetes. These results mean that insulin degludec is of use in routine clinical practice.
format Online
Article
Text
id pubmed-4718095
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-47180952016-01-26 Efficacy and safety of insulin degludec in Japanese patients with type 1 and type 2 diabetes: 24‐week results from the observational study in routine clinical practice Kobuke, Kazuhiro Yoneda, Masayasu Nakanishi, Shuhei Ohno, Haruya Maeda, Shusaku Egusa, Genshi J Diabetes Investig Articles This is first observational prospective study of insulin degludec in routine clinical practice that we evaluated the effect on glycemic control and risk of hypoglycemia in basal‐bolus insulin therapy. We found that insulin degludec can maintain glycemic control at a lower insulin dose and frequency of hypoglycemia in type 1 diabetes, while it can improve glycemic control at equally insulin dose in type 2 diabetes. These results mean that insulin degludec is of use in routine clinical practice. John Wiley and Sons Inc. 2015-06-10 2016-01 /pmc/articles/PMC4718095/ /pubmed/26816606 http://dx.doi.org/10.1111/jdi.12373 Text en © 2015 The Authors. Journal of Diabetes Investigation published by Asian Association of the Study of Diabetes (AASD) and Wiley Publishing Asia Pty Ltd This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Articles
Kobuke, Kazuhiro
Yoneda, Masayasu
Nakanishi, Shuhei
Ohno, Haruya
Maeda, Shusaku
Egusa, Genshi
Efficacy and safety of insulin degludec in Japanese patients with type 1 and type 2 diabetes: 24‐week results from the observational study in routine clinical practice
title Efficacy and safety of insulin degludec in Japanese patients with type 1 and type 2 diabetes: 24‐week results from the observational study in routine clinical practice
title_full Efficacy and safety of insulin degludec in Japanese patients with type 1 and type 2 diabetes: 24‐week results from the observational study in routine clinical practice
title_fullStr Efficacy and safety of insulin degludec in Japanese patients with type 1 and type 2 diabetes: 24‐week results from the observational study in routine clinical practice
title_full_unstemmed Efficacy and safety of insulin degludec in Japanese patients with type 1 and type 2 diabetes: 24‐week results from the observational study in routine clinical practice
title_short Efficacy and safety of insulin degludec in Japanese patients with type 1 and type 2 diabetes: 24‐week results from the observational study in routine clinical practice
title_sort efficacy and safety of insulin degludec in japanese patients with type 1 and type 2 diabetes: 24‐week results from the observational study in routine clinical practice
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718095/
https://www.ncbi.nlm.nih.gov/pubmed/26816606
http://dx.doi.org/10.1111/jdi.12373
work_keys_str_mv AT kobukekazuhiro efficacyandsafetyofinsulindegludecinjapanesepatientswithtype1andtype2diabetes24weekresultsfromtheobservationalstudyinroutineclinicalpractice
AT yonedamasayasu efficacyandsafetyofinsulindegludecinjapanesepatientswithtype1andtype2diabetes24weekresultsfromtheobservationalstudyinroutineclinicalpractice
AT nakanishishuhei efficacyandsafetyofinsulindegludecinjapanesepatientswithtype1andtype2diabetes24weekresultsfromtheobservationalstudyinroutineclinicalpractice
AT ohnoharuya efficacyandsafetyofinsulindegludecinjapanesepatientswithtype1andtype2diabetes24weekresultsfromtheobservationalstudyinroutineclinicalpractice
AT maedashusaku efficacyandsafetyofinsulindegludecinjapanesepatientswithtype1andtype2diabetes24weekresultsfromtheobservationalstudyinroutineclinicalpractice
AT egusagenshi efficacyandsafetyofinsulindegludecinjapanesepatientswithtype1andtype2diabetes24weekresultsfromtheobservationalstudyinroutineclinicalpractice

Ejemplares similares